Date and time
Start: Thursday 7 April 2022, 12:30 PM
End: Thursday 7 April 2022, 01:30 PM
Thursday 7 April
Start: Thursday 7 April 2022, 12:30 PM
End: Thursday 7 April 2022, 01:30 PM
An update on what has happened in SPCs over the last 2 years, including a look at recent decisions from the CJEU and an analysis of the post-Brexit landscape for SPCs in the UK.
All
Dr Duncan Curley has over 25 years of experience of patent and trademark dispute resolution. He is a pharmaceutical specialist and acts for a number of companies (large and small) on freedom to operate, patent clearance and litigation issues.
He has worked on many high profile cases over the years, including Krka and Consilient Health v AstraZeneca (damages inquiry), Aspire Pharma v Allergan (bimatoprost formulation patent), Dr Reddy’s v Warner-Lambert (SPC paediatric extension challenge) and two of the major UK cases on antitrust ‘Eurodefences’ to IP claims (Sandvik v Pfiffner, patents and Sportswear v Stonestyle, trade marks).
He is a frequent author of articles on IP issues and his publications include the book “Intellectual Property Licences and Technology Transfer” (on the European Technology Transfer Block Exemption) and “Extending Rewards for Innovative Drug Development”, a Report on Supplementary Protection Certificates published by the Intellectual Property Institute.
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here